Akihiro Tojo Selected Research

Akihiro Tojo Research Topics

Disease

10	Proteinuria 07/2012 - 01/2002
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013 - 01/2002
6	Albuminuria 12/2021 - 12/2002
5	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2021 - 06/2008
5	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019 - 12/2011
5	Diabetes Mellitus 06/2018 - 01/2002
5	Hyperplasia 01/2013 - 02/2003
5	Hypertension (High Blood Pressure) 02/2008 - 01/2003
4	Heart Failure 01/2022 - 12/2002
4	IGA Glomerulonephritis (IGA Nephropathy) 07/2015 - 01/2009
4	Membranous Glomerulonephritis (Membranous Nephropathy) 07/2015 - 05/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 07/2012 - 01/2003
3	Starvation 10/2020 - 01/2015
3	Glomerulonephritis 11/2019 - 12/2003
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2014 - 07/2012
2	Smoldering Multiple Myeloma 01/2022 - 03/2016
2	Vasculitis (Vasculitides) 09/2014 - 05/2012
2	Autoimmune Diseases (Autoimmune Disease) 09/2014 - 03/2013
2	Sclerosis 09/2004 - 04/2002
2	Inflammation (Inflammations) 09/2004 - 03/2004
1	Edema (Dropsy) 01/2022
1	Immunoglobulin Light-chain Amyloidosis 01/2022
1	Amyloidosis 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Headache (Headaches) 11/2019
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 11/2019
1	Renal Insufficiency (Renal Failure) 11/2019
1	Fever (Fevers) 11/2019
1	Acidosis 06/2018
1	Fanconi Syndrome (Syndrome, Fanconi) 03/2016
1	Infections 07/2015
1	Insulin Resistance 01/2015

Drug/Important Bio-Agent (IBA)

10	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013 - 01/2002
7	AlbuminsIBA 01/2019 - 05/2003
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2000
5	Streptozocin (Streptozotocin)FDA Link 06/2018 - 03/2004
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009 - 02/2003
5	SaltsIBA 02/2008 - 12/2002
5	NADP (NADPH)IBA 02/2008 - 12/2002
4	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2015
4	Angiotensin IIIBA 08/2007 - 04/2002
3	PuromycinIBA 12/2021 - 12/2011
3	Immunoglobulin G (IgG)IBA 11/2019 - 12/2003
3	Puromycin AminonucleosideIBA 06/2017 - 06/2008
3	Angiotensin Receptor AntagonistsIBA 01/2015 - 07/2006
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2014 - 05/2011
3	ReninIBA 01/2013 - 08/2007
3	AldosteroneIBA 01/2009 - 05/2007
3	Superoxides (Superoxide)IBA 02/2008 - 03/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2007 - 03/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 08/2007 - 01/2007
3	Superoxide DismutaseIBA 08/2007 - 03/2004
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2005 - 03/2004
2	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 03/2016
2	bafilomycin B1IBA 10/2020 - 06/2018
2	Albumin ReceptorsIBA 01/2019 - 01/2012
2	SodiumIBA 03/2016 - 01/2015
2	SymportersIBA 03/2016 - 01/2015
2	Eicosapentaenoic AcidIBA 09/2014 - 05/2012
2	SteroidsIBA 09/2014 - 01/2012
2	AntigensIBA 05/2013 - 05/2011
2	Carbonic Anhydrase IIIBA 05/2013 - 04/2007
2	AutoantibodiesIBA 05/2013 - 03/2013
2	Dihydrotachysterol (AT 10)IBA 01/2013 - 06/2008
2	AdrenomedullinIBA 01/2013 - 03/2004
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2009 - 07/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2007 - 01/2004
2	Spironolactone (Aldactone)FDA LinkGeneric 05/2007 - 07/2006
2	Eplerenone (Inspra)FDA LinkGeneric 05/2007 - 04/2005
2	tempolIBA 01/2007 - 03/2004
2	Dipyridamole (Persantine)FDA LinkGeneric 03/2006 - 02/2003
2	acetovanillone (apocynin)IBA 05/2005 - 03/2004
2	sapropterin (tetrahydrobiopterin)FDA Link 09/2004 - 02/2000
2	CreatinineIBA 09/2004 - 02/2000
2	Blood Glucose (Blood Sugar)IBA 09/2004 - 01/2002
2	3-nitrotyrosineIBA 09/2004 - 01/2002
2	CholesterolIBA 03/2004 - 01/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2002 - 02/2000
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	NucleosidesIBA 12/2021
1	Rituximab (Mabthera)FDA Link 11/2019
1	antiglomerular basement membrane antibodyIBA 11/2019
1	Cytoplasmic DyneinsIBA 01/2019
1	Myosins (Myosin)IBA 01/2019
1	Proton-Translocating ATPases (ATPase, H+)IBA 06/2018
1	Peptide Hydrolases (Proteases)FDA Link 03/2016
1	Uric Acid (Urate)IBA 03/2016
1	sodium phosphate (trisodium phosphate)FDA LinkGeneric 03/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	Phospholipase A2 ReceptorsIBA 07/2015

Therapy/Procedure

7	Therapeutics 11/2019 - 04/2002
2	Kidney Transplantation 07/2015 - 07/2012
1	Lasers (Laser) 01/2022
1	Intraperitoneal Injections 10/2020
1	Blood Component Removal (Apheresis) 01/2016
1	Transplantation 01/2016